Literature DB >> 12185194

CD26/DPPIV signal transduction function, but not proteolytic activity, is directly related to its expression level on human Th1 and Th2 cell lines as detected with living cell cytochemistry.

Emil P Boonacker1, Eddy A Wierenga, Hermelijn H Smits, Cornelis J F Van Noorden.   

Abstract

CD26/DPPIV is a cell surface glycoprotein that functions both in signal transduction and as a proteolytic enzyme, dipeptidyl peptidase IV (DPPIV). To investigate how two separate functions of one molecule are regulated, we analyzed CD26 protein expression and DPPIV enzyme activity on living human T-helper 1 (Th1) and Th2 cells that express different levels of CD26/DPPIV. DPPIV activity was specifically determined with the synthetic fluorogenic substrate ala-pro-cresyl violet and CD26 protein expression was demonstrated with an FITC-conjugated CD26-specific antibody. Fluorescence of liberated cresyl violet (red) and FITC (green) was detected simultaneously on living T-cells using flow cytometry and spectrofluorometry. Th1 cells expressed three- to sixfold more CD26 protein than Th2 cells. The signal transduction function of the CD26/DPPIV complex, tested by measuring its co-stimulatory potential for proliferation, was directly related to the amount of CD26 protein at the cell surface. However, DPPIV activity was similar in both cell populations at physiological substrate concentrations because of differences in K(m) and V(max) values of DPPIV on Th1 and Th2 cells. Western blotting and zymography of Th1 and Th2 whole-cell lysates demonstrated similar patterns. This study shows that two functions of one molecule can be controlled differentially.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12185194     DOI: 10.1177/002215540205000903

Source DB:  PubMed          Journal:  J Histochem Cytochem        ISSN: 0022-1554            Impact factor:   2.479


  10 in total

Review 1.  Imaging enzymes at work: metabolic mapping by enzyme histochemistry.

Authors:  Cornelis J F Van Noorden
Journal:  J Histochem Cytochem       Date:  2010-02-01       Impact factor: 2.479

2.  Early immune markers associated with Mycobacterium avium subsp. paratuberculosis infection in a neonatal calf model.

Authors:  J R Stabel; S Robbe-Austerman
Journal:  Clin Vaccine Immunol       Date:  2011-01-12

3.  Levels of dipeptidyl peptidase IV/CD26 substrates neuropeptide Y and vasoactive intestinal peptide in rheumatoid arthritis patients.

Authors:  Suncica Buljevic; Dijana Detel; Lara Baticic Pucar; Radovan Mihelic; Tomislav Madarevic; Branko Sestan; Jadranka Varljen
Journal:  Rheumatol Int       Date:  2013-07-18       Impact factor: 2.631

Review 4.  Regulation of Chemokine Activity - A Focus on the Role of Dipeptidyl Peptidase IV/CD26.

Authors:  Mieke Metzemaekers; Jo Van Damme; Anneleen Mortier; Paul Proost
Journal:  Front Immunol       Date:  2016-11-11       Impact factor: 7.561

Review 5.  A Comprehensive Review of Manifestations of Novel Coronaviruses in the Context of Deadly COVID-19 Global Pandemic.

Authors:  Aishwarya Gulati; Corbin Pomeranz; Zahra Qamar; Stephanie Thomas; Daniel Frisch; Gautam George; Ross Summer; Joseph DeSimone; Baskaran Sundaram
Journal:  Am J Med Sci       Date:  2020-05-11       Impact factor: 2.378

6.  Distinctive CD26 Expression on CD4 T-Cell Subsets.

Authors:  Oscar J Cordero; Carlos Rafael-Vidal; Rubén Varela-Calviño; Cristina Calviño-Sampedro; Beatriz Malvar-Fernández; Samuel García; Juan E Viñuela; José M Pego-Reigosa
Journal:  Biomolecules       Date:  2021-10-02

7.  Genetic ablation or pharmacological blockade of dipeptidyl peptidase IV does not impact T cell-dependent immune responses.

Authors:  Kalpit A Vora; Gene Porter; Roche Peng; Yan Cui; Kellyann Pryor; George Eiermann; Dennis M Zaller
Journal:  BMC Immunol       Date:  2009-04-09       Impact factor: 3.615

8.  Safety and tolerability of sitagliptin in patients with type 2 diabetes: a pooled analysis.

Authors:  Debora Williams-Herman; Elizabeth Round; Arlene S Swern; Bret Musser; Michael J Davies; Peter P Stein; Keith D Kaufman; John M Amatruda
Journal:  BMC Endocr Disord       Date:  2008-10-27       Impact factor: 2.763

9.  Type 1 Diabetes Prevention in NOD Mice by Targeting DPPIV/CD26 Is Associated with Changes in CD8⁺T Effector Memory Subset.

Authors:  Núria Alonso; María Teresa Julián; Jorge Carrascal; Roger Colobran; Irma Pujol-Autonell; Silvia Rodriguez-Fernández; Aina Teniente; Marco Antonio Fernández; Antoni Miñarro; María Carmen Ruiz de Villa; Marta Vives-Pi; Manel Puig-Domingo
Journal:  PLoS One       Date:  2015-11-10       Impact factor: 3.240

10.  Dipeptidyl peptidase 10, a novel prognostic marker in colorectal cancer.

Authors:  Heae Surng Park; Hyun Yang Yeo; Hee Jin Chang; Kyung-Hee Kim; Ji Won Park; Byung Chang Kim; Ji Yeon Baek; Sun Young Kim; Dae Yong Kim
Journal:  Yonsei Med J       Date:  2013-11       Impact factor: 2.759

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.